Your browser doesn't support javascript.
SARS-CoV-2 Vaccine Acceptability in Patients on Hemodialysis: A Nationwide Survey.
Garcia, Pablo; Montez-Rath, Maria E; Moore, Heather; Flotte, Johnie; Fults, Chris; Block, Martha S; Han, Jialin; Dittrich, Mary; Parsonnet, Julie; Chertow, Glenn M; Block, Geoffrey A; Anand, Shuchi.
  • Garcia P; Department of Medicine (Nephrology), Stanford University, Stanford, California.
  • Montez-Rath ME; Department of Medicine (Nephrology), Stanford University, Stanford, California.
  • Moore H; Office of the Chief Medical Officer, US Renal Care, Plano, Texas.
  • Flotte J; Office of the Chief Medical Officer, US Renal Care, Plano, Texas.
  • Fults C; Office of the Chief Medical Officer, US Renal Care, Plano, Texas.
  • Block MS; Office of the Chief Medical Officer, US Renal Care, Plano, Texas.
  • Han J; Department of Medicine (Nephrology), Stanford University, Stanford, California.
  • Dittrich M; Office of the Chief Medical Officer, US Renal Care, Plano, Texas.
  • Parsonnet J; Departments of Medicine (Infectious Diseases and Geographic Medicine), and Epidemiology and Population Health, Stanford University, Stanford, California.
  • Chertow GM; Departments of Medicine (Nephrology), and Epidemiology and Population Health, Stanford University, Stanford, California.
  • Block GA; Office of the Chief Medical Officer, US Renal Care, Plano, Texas.
  • Anand S; Department of Medicine (Nephrology), Stanford University, Stanford, California sanand2@stanford.edu.
J Am Soc Nephrol ; 2021 Apr 29.
Article in English | MEDLINE | ID: covidwho-1394648
ABSTRACT

BACKGROUND:

Patients on dialysis are at increased risk for COVID-19-related complications. However, a substantial fraction of patients on dialysis belong to groups more likely to be hesitant about vaccination.

METHODS:

With the goal of identifying strategies to increase COVID-19 vaccine uptake among patients on hemodialysis, we conducted a nationwide vaccine acceptability survey, partnering with a dialysis network to distribute an anonymized English and Spanish language online survey in 150 randomly selected facilities in the United States. We used logistic regression to evaluate characteristics of vaccine-hesitant persons.

RESULTS:

A total of 1515 (14% of eligible) patients responded; 20% of all responders, 29% of patients aged 18-44 years, and 29% of Black responders reported being hesitant to seek the COVID-19 vaccine, even if the vaccine was considered safe for the general population. Odds of vaccine hesitancy were higher among patients aged 18-44 years versus those 45-64 years (odds ratio [OR], 1.5; 95% confidence interval [95% CI], 1.0 to 2.3), Black patients versus non-Hispanic White patients (OR, 1.9; 95% CI, 1.3 to 2.7), Native Americans or Pacific Islanders versus non-Hispanic White patients (OR, 2.0; 95% CI, 1.1 to 3.7), and women versus men (OR, 1.6; 95% CI, 1.2 to 2.0). About half (53%) of patients who were vaccine hesitant expressed concerns about side effects. Responders' main information sources about COVID-19 vaccines were television news and dialysis staff (68% and 38%, respectively).

CONCLUSIONS:

A substantial proportion of patients receiving in-center hemodialysis in the United States are hesitant about seeking COVID-19 vaccination. Facilitating uptake requires outreach to younger patients, women, and Black, Native American, or Pacific Islander patients, and addressing concerns about side effects.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Document Type: Article Type of study: Prognostic study Language: English Clinical aspect: Etiology Year: 2021

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Document Type: Article Type of study: Prognostic study Language: English Clinical aspect: Etiology Year: 2021
...